Caspian Journal of Internal Medicine
Babol University of Medical Sciences
پنجشنبه 29 شهریور 1403
[Archive]
دوره 9، شماره 2 - ( 10-1396 )
جلد 9 شماره 2 صفحات 139-134 |
برگشت به فهرست نسخه ها
Download citation:
BibTeX | RIS | EndNote | Medlars | ProCite | Reference Manager | RefWorks
Send citation to:
BibTeX | RIS | EndNote | Medlars | ProCite | Reference Manager | RefWorks
Send citation to:
ahmadi N, Mahjoub S, Hajihosseini R, Taherkhani M, Moslemi D. Alterations in serum levels of trace element in patients with breast cancer before and after chemotherapy. Caspian J Intern Med 2018; 9 (2) :134-139
URL: http://caspjim.com/article-1-1149-fa.html
URL: http://caspjim.com/article-1-1149-fa.html
Alterations in serum levels of trace element in patients with breast cancer before and after chemotherapy. . 1396; 9 (2) :134-139
چکیده: (7354 مشاهده)
Background: Breast cancer is the most common serious disease around the world. The trace elements have a vital role in the metabolism and chemotherapy may change the level of metal ions. Due to the ambiguity of the existence in this regard, the study examined the trace element serum levels in women with breast cancer before and after chemotherapy .
Methods: Sixty patients were studied undergoing specialist. First sampling was taken before chemotherapy (after 4 weeks of surgery) and second sampling was taken after the completion of 3 courses of chemotherapy, approximately 9 weeks after the first chemotherapy. The patients took Adriamycin 60mg/m2 Cytoxan 600mg/m2. Serum zinc and iron levels were measured using standard spectrophotometric method. Measurement of serum copper was done by atomic absorption spectroscopy.
Results: Serum zinc and iron levels in women after chemotherapy significantly decreased (p<0.001), however, the serum level of copper increased but was not significant (P=0.676).
Conclusions: Our findings demonstrate significant decrease in zinc and iron levels in breast cancer patients after 3 courses of Adriamycin and Cytoxan chemotherapy. Prescribing zinc supplements can be useful after chemotherapy
Methods: Sixty patients were studied undergoing specialist. First sampling was taken before chemotherapy (after 4 weeks of surgery) and second sampling was taken after the completion of 3 courses of chemotherapy, approximately 9 weeks after the first chemotherapy. The patients took Adriamycin 60mg/m2 Cytoxan 600mg/m2. Serum zinc and iron levels were measured using standard spectrophotometric method. Measurement of serum copper was done by atomic absorption spectroscopy.
Results: Serum zinc and iron levels in women after chemotherapy significantly decreased (p<0.001), however, the serum level of copper increased but was not significant (P=0.676).
Conclusions: Our findings demonstrate significant decrease in zinc and iron levels in breast cancer patients after 3 courses of Adriamycin and Cytoxan chemotherapy. Prescribing zinc supplements can be useful after chemotherapy
نوع مطالعه: Original Article |
موضوع مقاله:
Biochimestry
دریافت: 1396/4/27 | پذیرش: 1396/9/2 | انتشار: 1396/10/18
دریافت: 1396/4/27 | پذیرش: 1396/9/2 | انتشار: 1396/10/18
| بازنشر اطلاعات | |
 |
این مقاله تحت شرایط Creative Commons Attribution-NonCommercial 4.0 International License قابل بازنشر است. |
